VON WILLEBRAND DISEASE, TYPE 3
Clinical trials for VON WILLEBRAND DISEASE, TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE, TYPE 3 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE, TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial for bleeding disorder drug in toddlers pulled before it started
Disease control TerminatedThis study was designed to test how FANHDI, a clotting factor concentrate, works in children under 6 with severe von Willebrand disease (types 2 or 3). The goal was to measure how the drug moves through the body and how well it controls bleeding. However, the trial was withdrawn …
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Phase: PHASE4 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Real-World study tracks bleeding and daily life in rare bleeding disorder
Knowledge-focused OngoingThis study observes 44 people with type 3 von Willebrand disease, a rare bleeding disorder, who are already on standard preventive treatment. Researchers will track how often bleeding episodes occur and how the condition affects quality of life over at least 24 weeks. No new drug…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC